Companies / BOC Sciences / Nesvacumab
BOC Sciences

Nesvacumab | BOC Sciences

Nesvacumab is a human monoclonal antibody targeting Angiopoietin 2. Nesvacumab has the potential for the treatment of various cancers.

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.